Reactions 1704, p289 - 2 Jun 2018 Neutropenia complicated by engraftment syndrome and shock: case report A 71-year-old woman developed neutropenia complicated by engraftment syndrome and shock following treatment with paclitaxel [nabPTX] for breast cancer [route, dosage and time to reaction onset not stated]. The woman, who was diagnosed with left breast cancer, underwent surgery. After the surgery, she received adjuvant chemotherapy with epirubicin and cyclophosphamide, which was followed by treatment with paclitaxel and trastuzumab therapy. She was hospitalised due to severe neutropenia with neutrophil count of 0 /mm . After admission her condition stabilised. However, after three days, she went into a shock and was transferred to the ICU. The woman was treated with cytokine adsorption therapy, after which her condition improved rapidly. After five days, she was extubated and was shifted to the general ward. Eventually, she was discharged without any problems in the next few months. As a significant improvement was observed in her condition after cytokine adsorption therapy, engraftment syndrome was considered. Author comment: "The patient was hospitalized due to severe neutropenia(neutrophils 0/mm3) from [paclitaxel]". "In this case, FN or cardiovascular diseases was ruled out, and engraftment syndrome was considered given that cytokine adsorption therapy significantly improved the patient’s condition." Yoshikawa K, et al. [A Case of Shock Due to nabPTX Administration Successfully Treated with Cytokine Adsorption Therapy]. Gan to Kagaku Ryoho 44: 1358-1360, No. 12, Nov 2017 [Japanese; summarised from an English abstract] - Japan 803322725 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud